Alzheimer’s Therapeutics Market Size, Share & Trends Report

Alzheimer’s Therapeutics Market Size, Share & Trends Analysis By Product (Cholinesterase Inhibitors, NMDA Receptor Antagonist, Combination Drug, Pipeline Drugs), By End-user, By Region, And Segment Forecasts, 2023 - 2030

  • Report ID: GVR-1-68038-123-8
  • Number of Pages: 103
  • Format: Electronic (PDF)
  • Historical Range: 2018 - 2021
  • Industry: Healthcare

Market Segmentation 

  • Alzheimer’s Therapeutics Product Outlook (Revenue, USD Million, 2018 - 2030)
    • Cholinesterase inhibitors
      • Donepezil
      • Galantamine
      • Rivastigmine
    • NMDA Receptor Antagonist
    • Combination Drug
    • Pipeline Drugs
  • Alzheimer’s Therapeutics End User Outlook (Revenue, USD Million, 2018 - 2030)
    • Hospital Pharmacy
    • Retail Pharmacy
    • E-commerce
  • Alzheimer’s Therapeutics Regional Outlook (Revenue, USD Million, 2018 - 2030)
    • North America
      • North America Alzheimer’s Therapeutics Market, By Product
        • Cholinesterase inhibitors
          • Donepezil
          • Galantamine
          • Rivastigmine
        • NMDA Receptor Antagonist
        • Combination Drug
        • Pipeline Drugs
      • North America Alzheimer’s Therapeutics Market, By End User
        • Hospital Pharmacy
        • Retail Pharmacy
        • E-commerce
      • U.S.
        • U.S. Alzheimer’s Therapeutics Market, By Product
          • Cholinesterase inhibitors
            • Donepezil
            • Galantamine
            • Rivastigmine
          • NMDA Receptor Antagonist
          • Combination Drug
          • Pipeline Drugs
        • U.S. Alzheimer’s Therapeutics Market, By End User
          • Hospital Pharmacy
          • Retail Pharmacy
          • E-commerce
      • Canada
        • Canada Alzheimer’s Therapeutics Market, By Product
          • Cholinesterase inhibitors
            • Donepezil
            • Galantamine
            • Rivastigmine
          • NMDA Receptor Antagonist
          • Combination Drug
          • Pipeline Drugs
        • Canada Alzheimer’s Therapeutics Market, By End User
          • Hospital Pharmacy
          • Retail Pharmacy
          • E-commerce
    • Europe
      • Europe Alzheimer’s Therapeutics Market, By Product
        • Cholinesterase inhibitors
          • Donepezil
          • Galantamine
          • Rivastigmine
        • NMDA Receptor Antagonist
        • Combination Drug
        • Pipeline Drugs
      • Europe Alzheimer’s Therapeutics Market, By End User
        • Hospital Pharmacy
        • Retail Pharmacy
        • E-commerce
      • Germany
        • Germany Alzheimer’s Therapeutics Market, By Product
          • Cholinesterase inhibitors
            • Donepezil
            • Galantamine
            • Rivastigmine
          • NMDA Receptor Antagonist
          • Combination Drug
          • Pipeline Drugs
        • Germany Alzheimer’s Therapeutics Market, By End User
          • Hospital Pharmacy
          • Retail Pharmacy
          • E-commerce
      • U.K.
        • U.K. Alzheimer’s Therapeutics Market, By Product
          • Cholinesterase inhibitors
            • Donepezil
            • Galantamine
            • Rivastigmine
          • NMDA Receptor Antagonist
          • Combination Drug
          • Pipeline Drugs
        • U.K. Alzheimer’s Therapeutics Market, By End User
          • Hospital Pharmacy
          • Retail Pharmacy
          • E-commerce
      • Spain
        • Spain Alzheimer’s Therapeutics Market, By Product
          • Cholinesterase inhibitors
            • Donepezil
            • Galantamine
            • Rivastigmine
          • NMDA Receptor Antagonist
          • Combination Drug
          • Pipeline Drugs
        • Spain Alzheimer’s Therapeutics Market, By End User
          • Hospital Pharmacy
          • Retail Pharmacy
          • E-commerce
      • France
        • France Alzheimer’s Therapeutics Market, By Product
          • Cholinesterase inhibitors
            • Donepezil
            • Galantamine
            • Rivastigmine
          • NMDA Receptor Antagonist
          • Combination Drug
          • Pipeline Drugs
        • France Alzheimer’s Therapeutics Market, By End User
          • Hospital Pharmacy
          • Retail Pharmacy
          • E-commerce
      • Italy
        • Italy Alzheimer’s Therapeutics Market, By Product
          • Cholinesterase inhibitors
            • Donepezil
            • Galantamine
            • Rivastigmine
          • NMDA Receptor Antagonist
          • Combination Drug
          • Pipeline Drugs
        • Italy Alzheimer’s Therapeutics Market, By End User
          • Hospital Pharmacy
          • Retail Pharmacy
          • E-commerce
      • Denmark
        • Denmark Alzheimer’s Therapeutics Market, By Product
          • Cholinesterase inhibitors
            • Donepezil
            • Galantamine
            • Rivastigmine
          • NMDA Receptor Antagonist
          • Combination Drug
          • Pipeline Drugs
        • Denmark Alzheimer’s Therapeutics Market, By End User
          • Hospital Pharmacy
          • Retail Pharmacy
          • E-commerce
      • Sweden
        • Sweden Alzheimer’s Therapeutics Market, By Product
          • Cholinesterase inhibitors
            • Donepezil
            • Galantamine
            • Rivastigmine
          • NMDA Receptor Antagonist
          • Combination Drug
          • Pipeline Drugs
        • Sweden Alzheimer’s Therapeutics Market, By End User
          • Hospital Pharmacy
          • Retail Pharmacy
          • E-commerce
      • Norway
        • Norway Alzheimer’s Therapeutics Market, By Product
          • Cholinesterase inhibitors
            • Donepezil
            • Galantamine
            • Rivastigmine
          • NMDA Receptor Antagonist
          • Combination Drug
          • Pipeline Drugs
        • Norway Alzheimer’s Therapeutics Market, By End User
          • Hospital Pharmacy
          • Retail Pharmacy
          • E-commerce
    • Asia Pacific
      • Asia Pacific Alzheimer’s Therapeutics Market, By Product
        • Cholinesterase inhibitors
          • Donepezil
          • Galantamine
          • Rivastigmine
        • NMDA Receptor Antagonist
        • Combination Drug
        • Pipeline Drugs
      • Asia Pacific Alzheimer’s Therapeutics Market, By End User
        • Hospital Pharmacy
        • Retail Pharmacy
        • E-commerce
      • Japan
        • Japan Alzheimer’s Therapeutics Market, By Product
          • Cholinesterase inhibitors
            • Donepezil
            • Galantamine
            • Rivastigmine
          • NMDA Receptor Antagonist
          • Combination Drug
          • Pipeline Drugs
        • Japan Alzheimer’s Therapeutics Market, By End User
          • Hospital Pharmacy
          • Retail Pharmacy
          • E-commerce
      • China
        • China Alzheimer’s Therapeutics Market, By Product
          • Cholinesterase inhibitors
            • Donepezil
            • Galantamine
            • Rivastigmine
          • NMDA Receptor Antagonist
          • Combination Drug
          • Pipeline Drugs
        • China Alzheimer’s Therapeutics Market, By End User
          • Hospital Pharmacy
          • Retail Pharmacy
          • E-commerce
      • India
        • India Alzheimer’s Therapeutics Market, By Product
          • Cholinesterase inhibitors
            • Donepezil
            • Galantamine
            • Rivastigmine
          • NMDA Receptor Antagonist
          • Combination Drug
          • Pipeline Drugs
        • India Alzheimer’s Therapeutics Market, By End User
          • Hospital Pharmacy
          • Retail Pharmacy
          • E-commerce
      • South Korea
        • South Korea Alzheimer’s Therapeutics Market, By Product
          • Cholinesterase inhibitors
            • Donepezil
            • Galantamine
            • Rivastigmine
          • NMDA Receptor Antagonist
          • Combination Drug
          • Pipeline Drugs
        • South Korea Alzheimer’s Therapeutics Market, By End User
          • Hospital Pharmacy
          • Retail Pharmacy
          • E-commerce
      • Thailand
        • Thailand Alzheimer’s Therapeutics Market, By Product
          • Cholinesterase inhibitors
            • Donepezil
            • Galantamine
            • Rivastigmine
          • NMDA Receptor Antagonist
          • Combination Drug
          • Pipeline Drugs
        • Thailand Alzheimer’s Therapeutics Market, By End User
          • Hospital Pharmacy
          • Retail Pharmacy
          • E-commerce
      • Australia
        • Australia  Alzheimer’s Therapeutics Market, By Product
          • Cholinesterase inhibitors
            • Donepezil
            • Galantamine
            • Rivastigmine
          • NMDA Receptor Antagonist
          • Combination Drug
          • Pipeline Drugs
        • Australia Alzheimer’s Therapeutics Market, By End User
          • Hospital Pharmacy
          • Retail Pharmacy
          • E-commerce
    • Latin America
      • Latin America Alzheimer’s Therapeutics Market, By Product
        • Cholinesterase inhibitors
          • Donepezil
          • Galantamine
          • Rivastigmine
        • NMDA Receptor Antagonist
        • Combination Drug
        • Pipeline Drugs
      • Latin America Alzheimer’s Therapeutics Market, By End User
        • Hospital Pharmacy
        • Retail Pharmacy
        • E-commerce
      • Brazil
        • Brazil Alzheimer’s Therapeutics Market, By Product
          • Cholinesterase inhibitors
            • Donepezil
            • Galantamine
            • Rivastigmine
          • NMDA Receptor Antagonist
          • Combination Drug
          • Pipeline Drugs
        • Brazil Alzheimer’s Therapeutics Market, By End User
          • Hospital Pharmacy
          • Retail Pharmacy
          • E-commerce
      • Mexico
        • Mexico Alzheimer’s Therapeutics Market, By Product
          • Cholinesterase inhibitors
            • Donepezil
            • Galantamine
            • Rivastigmine
          • NMDA Receptor Antagonist
          • Combination Drug
          • Pipeline Drugs
        • Mexico Alzheimer’s Therapeutics Market, By End User
          • Hospital Pharmacy
          • Retail Pharmacy
          • E-commerce
      • Argentina
        • Argentina Alzheimer’s Therapeutics Market, By Product
          • Cholinesterase inhibitors
            • Donepezil
            • Galantamine
            • Rivastigmine
          • NMDA Receptor Antagonist
          • Combination Drug
          • Pipeline Drugs
        • Argentina Alzheimer’s Therapeutics Market, By End User
          • Hospital Pharmacy
          • Retail Pharmacy
          • E-commerce
    • MEA
      • MEA Alzheimer’s Therapeutics Market, By Product
        • Cholinesterase inhibitors
          • Donepezil
          • Galantamine
          • Rivastigmine
        • NMDA Receptor Antagonist
        • Combination Drug
        • Pipeline Drugs
      • MEA Alzheimer’s Therapeutics Market, By End User
        • Hospital Pharmacy
        • Retail Pharmacy
        • E-commerce
      • South Africa
        • South Africa Alzheimer’s Therapeutics Market, By Product
          • Cholinesterase inhibitors
            • Donepezil
            • Galantamine
            • Rivastigmine
          • NMDA Receptor Antagonist
          • Combination Drug
          • Pipeline Drugs
        • South Africa Alzheimer’s Therapeutics Market, By End User
          • Hospital Pharmacy
          • Retail Pharmacy
          • E-commerce
      • Saudi Arabia
        • Saudi Arabia Alzheimer’s Therapeutics Market, By Product
          • Cholinesterase inhibitors
            • Donepezil
            • Galantamine
            • Rivastigmine
          • NMDA Receptor Antagonist
          • Combination Drug
          • Pipeline Drugs
        • Saudi Arabia Alzheimer’s Therapeutics Market, By End User
          • Hospital Pharmacy
          • Retail Pharmacy
          • E-commerce
      • UAE
        • UAE Alzheimer’s Therapeutics Market, By Product
          • Cholinesterase inhibitors
            • Donepezil
            • Galantamine
            • Rivastigmine
          • NMDA Receptor Antagonist
          • Combination Drug
          • Pipeline Drugs
        • UAE Alzheimer’s Therapeutics Market, By End User
          • Hospital Pharmacy
          • Retail Pharmacy
          • E-commerce
      • Kuwait
        • Kuwait Alzheimer’s Therapeutics Market, By Product
          • Cholinesterase inhibitors
            • Donepezil
            • Galantamine
            • Rivastigmine
          • NMDA Receptor Antagonist
          • Combination Drug
          • Pipeline Drugs
        • Kuwait Alzheimer’s Therapeutics Market, By End User
          • Hospital Pharmacy
          • Retail Pharmacy
          • E-commerce

Report content

Qualitative Analysis

  • Industry overview
  • Industry trends
  • Market drivers and restraints
  • Market size
  • Growth prospects
  • Porter’s analysis
  • PESTEL analysis
  • Key market opportunities prioritized
  • Competitive landscape
    • Company overview
    • Financial performance
    • Product benchmarking
    • Latest strategic developments

Quantitative Analysis

  • Market size, estimates, and forecast from 2018 to 2030
  • Market estimates and forecast for product segments up to 2030
  • Regional market size and forecast for product segments up to 2030
  • Market estimates and forecast for application segments up to 2030
  • Regional market size and forecast for application segments up to 2030
  • Company financial performance
What questions do you have? Get quick response from our industry experts. Request a Free Consultation
pdf

GET A FREE SAMPLE

bck

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

cog

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

ISO

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon